Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-03-06

FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The supplemental action pertains to chan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEGRETOL (CARBAMAZEPINE)

Snippet

SUPPL AP for TEGRETOL (CARBAMAZEPINE)